Related Experiment Video
Updated: Jun 15, 2026

Modeling Multiple Sclerosis in the Two Sexes: MOG35-55-Induced Experimental Autoimmune Encephalomyelitis
Published on: October 13, 2023
Benign multiple sclerosis in Crete
V Mastorodemos1, H Nikolakaki, M Tzagournissakis
1Department of Neurology and the Neurology Service of the University Hospital, School of Health Sciences, University of Crete, Heraklion, Crete, Greece.
Multiple sclerosis (MS) in Crete shows a benign course in a significant proportion of patients. Factors like younger age at onset and fewer relapses are linked to this favorable multiple sclerosis prognosis.
Area of Science:
- Neurology
- Epidemiology
- Genetics
Background:
- Multiple sclerosis (MS) prevalence and characteristics can vary geographically.
- Understanding MS in isolated populations like Crete offers insights into genetic and environmental factors.
Purpose of the Study:
- To investigate the epidemiology and clinical course of multiple sclerosis (MS) on the island of Crete.
- To identify factors associated with a benign disease progression in MS patients.
Main Methods:
- Case ascertainment through the MS Epidemiology Program Project of Crete.
- Diagnosis and classification using established clinical and MRI criteria.
- Detailed clinical evaluations, laboratory tests, and a 36-item questionnaire for prognosis analysis.
Main Results:
- Identified 587 MS cases, predominantly of Cretan origin.
- Average age at onset was 31.5 years; average disease duration was 12.7 years.
- Nearly 40% of patients with >10 years of disease duration had mild disability (EDSS ≤3); 30% of relapsing-remitting MS patients had benign evolution (>20 years, EDSS ≤3).
Conclusions:
- A substantial proportion of multiple sclerosis patients from Crete exhibit a benign disease course.
- This benign MS progression may be influenced by the population's genetic background and/or environmental factors.
Related Concept Videos
Multiple Sclerosis l: Introduction
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Myasthenia Gravis ll: Pathophysiology
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...

